Does oral administration of ketamine accelerate response to treatment in major depressive disorder? Results of a double-blind controlled trial

Major depressive disorder (MDD) exerts a high health and financial burden on society. The conventional pharmacotherapies for MDD are partially effective and the response to medication often starts with some delay. There are recent reports of antidepressant effects for oral ketamine. We employed a do...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of affective disorders 2018-08, Vol.235, p.236-241
Hauptverfasser:	Arabzadeh, Somaye, Hakkikazazi, Elham, Shahmansouri, Nazila, Tafakhori, Abbas, Ghajar, Alireza, Jafarinia, Morteza, Akhondzadeh, Shahin
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Adult Depressive Disorder, Major - drug therapy Double-Blind Method Excitatory Amino Acid Antagonists - administration & dosage Female Humans Ketamine - administration & dosage Male Middle Aged Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!